Newleos Therapeutics
Boston, US · Founded 2024 · Delaware corporation · 29 employees on LinkedIn · 6 known investors
Find your way into Newleos Therapeutics
433 people in our graph share verified history with the Newleos Therapeutics team — schools, employers, funds. One of them is your warm intro.
John McCulloughunlockedknows Rob Hadfield · together at Providence College (overlapped)
×2knows the team · via Isenberg School of Management, UMass Amherst
×6knows the team · via Georgetown Law
×2knows the team · via Cowen and Company
knows the team · via Providence College
Founders & leadership
DD
RH
JM
Board
CW
MC
RC
Investors · 6
DCVC (Data Collective)Palo Alto · $5M – $25M
DCVC BioPalo Alto
Longwood Fundreported · 3 sourcesBostonvia Christoph Westphal · board
Novo Holdingsreported · 2 sourcesCopenhagen · $1.1M – $54M
Also in the syndicate · 2
Arkin Bio CapitalGoldman Sachs Alternativeslead
Reported raises · per SEC filings
Form D private placements$93.4M disclosed across 1 round · 2025
▶$93.4MraisedFeb 2025 · 11 investors · BiotechnologyRule 506(b)
▶$93.4MraisedFeb 2025 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David DonabedianExecutive Officer, Director
- Robert HadfieldExecutive Officer
- Christoph WestphalDirector
- Ming CheahDirector
- Raymond CamahortDirector
- John McCabeExecutive Officer
- Offering amount
- $93.4M
- Amount sold
- $93.4M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Newleos Therapeutics's investors?
- Newleos Therapeutics's investors include DCVC (Data Collective), DCVC Bio, Longwood Fund, Novo Holdings.
- How much funding has Newleos Therapeutics raised?
- Newleos Therapeutics has disclosed $93.4M raised across 1 round.
- Where is Newleos Therapeutics headquartered?
- Newleos Therapeutics is headquartered in Boston, US.